Overview

Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

Status:
Terminated

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

This study will help determine if behavior modification performed in conjunction with oral Vesicare anticholinergic therapy is more effective for treating overactive bladder symptoms than oral Vesicare anticholinergic therapy alone.

Phase:

Phase 3

Details

Lead Sponsor:

Lahey Clinic

Collaborator:

Astellas Pharma US, Inc.

Treatments:

Solifenacin Succinate